Cambridge Acquisition Corp.: management transactions · United States · SEC (Form 4)

About Cambridge Acquisition Corp.

Cambridge Acquisition Corp. is a U.S.-based special purpose acquisition company (SPAC) listed on the NASDAQ under the ticker CAQ. At this stage, it does not operate as a conventional operating business with revenues, products, or an established industrial footprint. Its core mandate is to complete a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more private businesses. For investors, the company should therefore be viewed primarily as a publicly traded acquisition vehicle rather than an operating issuer. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0002100125/000110465926036095/caq-20251231x10k.htm)) The company is newly formed, reflecting the 2025-2026 SPAC issuance cycle in the U.S. capital markets. SEC filings show a standard SPAC capital structure with Class A ordinary shares, founder Class B ordinary shares, and public warrants. Cambridge Acquisition’s units began trading on February 6, 2026 on the NASDAQ Global Market, and the company’s principal business address is One Liberty Square, 13th FL, Boston, MA 02109, Boston, Massachusetts, United States. Those details confirm both the market venue and the country context relevant for international investors. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0002100125/000110465926036095/caq-20251231x10k.htm)) From a competitive standpoint, Cambridge Acquisition Corp. sits in one of the most crowded segments of the U.S. listing market: SPACs competing for attractive targets, investor support, and execution credibility. Because SPACs do not compete through product features, differentiation comes from sponsor reputation, transaction sourcing, sector access, and the ability to negotiate a high-quality deal within the available time window. The SEC filings identify Brent Michael Cox as Director and Chief Executive Officer, with experience in private equity, investing, and transaction execution. That background suggests a team oriented toward deal sourcing and capital allocation, although the company has not yet disclosed a de-SPAC target or a post-combination operating thesis. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0002100125/000110465926036095/caq-20251231x10k.htm)) Cambridge Acquisition Corp. does not currently have business lines in the traditional sense. Its “offering” is financial structuring: it raises IPO proceeds, places them in trust, and seeks to deploy that capital into a target transaction. The filing states that the public proceeds and private placement proceeds remain restricted until an initial business combination is completed, public shares are redeemed if no deal is achieved within the prescribed timeframe, or another qualifying corporate event occurs. This makes the company highly event-driven: valuation and performance are tied less to recurring fundamentals and more to the probability, quality, timing, and terms of the eventual acquisition. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0002100125/000110465926036095/caq-20251231x10k.htm)) Recent notable developments center on the IPO and listing process in early 2026, rather than operational milestones. SEC disclosures also outline the sponsor ownership structure, founder share economics, and the usual SPAC governance and conflict-of-interest framework. For investors following U.S.-listed Form 4 insider activity, Cambridge Acquisition Corp. is therefore best understood as a newly listed NASDAQ SPAC in the United States, with the investment case resting on sponsor execution, target selection, and eventual business combination outcomes rather than on current operating performance. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0002100125/000110465926036095/caq-20251231x10k.htm))